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A B S T R A C T
Background
Neonatal hypothyroidism has been associated in animal models with maternal exposure to
several environmental contaminants; however, evidence for such an association in humans is
inconsistent. We evaluated whether maternal exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin
(TCDD), a persistent and widespread toxic environmental contaminant, is associated with
modified neonatal thyroid function in a large, highly exposed population in Seveso, Italy.
Methods and Findings
Between 1994 and 2005, in individuals exposed to TCDD after the 1976 Seveso accident we
conducted: (i) a residence-based population study on 1,014 children born to the 1,772 women
of reproductive age in the most contaminated zones (A, very high contamination; B, high
contamination), and 1,772 age-matched women from the surrounding noncontaminated area
(reference); (ii) a biomarker study on 51 mother–child pairs for whom recent maternal plasma
dioxin measurements were available. Neonatal blood thyroid-stimulating hormone (b-TSH) was
measured on all children. We performed crude and multivariate analyses adjusting for gender,
birth weight, birth order, maternal age, hospital, and type of delivery. Mean neonatal b-TSH was
0.98 lU/ml (95% confidence interval [CI] 0.90–1.08) in the reference area (n¼ 533), 1.35 lU/ml
(95% CI 1.22–1.49) in zone B (n¼ 425), and 1.66 lU/ml (95% CI 1.19–2.31) in zone A (n¼ 56) (p
, 0.001). The proportion of children with b-TSH . 5 lU/ml was 2.8% in the reference area,
4.9% in zone B, and 16.1% in zone A (p , 0.001). Neonatal b-TSH was correlated with current
maternal plasma TCDD (n¼ 51, b¼ 0.47, p , 0.001) and plasma toxic equivalents of coplanar
dioxin-like compounds (n¼ 51, b ¼ 0.45, p¼ 0.005).
Conclusions
Our data indicate that environmental contaminants such as dioxins have a long-lasting
capability to modify neonatal thyroid function after the initial exposure.
The Editors’ Summary of this article follows the references.
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Introduction
Variations in neonatal thyroid function evaluated at birth
through blood thyroid-stimulating hormone (b-TSH) are
associated with changes in iodine availability and maternal
intake [1]. According to the World Health Organization
(WHO), the percentage of newborns with b-TSH . 5 lU/ml
should be less than 3% in iodine-replete populations [1].
Aside from iodine deﬁciency, no environmental exposure has
been conclusively associated with reduced neonatal thyroid
function in humans [2–4].
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), a ubiquitous
low-level contaminant of the environment, is the most toxic
compound of a class of toxicologically related environmental
chemicals, including other dioxins, polychlorinated biphenyls
(PCBs), furans, brominated compounds, polycyclic aromatic
hydrocarbons, and organochlorine pesticides [5,6]. High
exposures to dioxin have occurred in chemical workers,
Vietnam Agent Orange veteran sprayers, accidental rice oil
contamination, and recent isolated poisonings such as those
of the current Ukrainian president and of ﬁve coworkers, two
of whom had particularly elevated exposures, in Vienna,
Austria [6]. In animal models, maternal exposure to TCDD
induces elevated b-TSH and neonatal primary hypothyroid-
ism [2,7–10], as TCDD and other related compounds have
been shown to accelerate thyroid hormone clearance by
increasing metabolic enzyme activity and competing with
plasma binding proteins [11–13].
In July 1976, an industrial accident caused the exposure to
high TCDD doses of a large population living in a residential
area in Seveso, Italy [14]. TCDD has an extremely long half
life, particularly in women (;10 y) [15,16], and was still
elevated in plasma samples collected from exposed women 20
y after the accident [17,18]. Starting in 1994, we conducted
two related investigations on the Seveso population to
determine whether maternal exposure to TCDD, as well as
elevated current plasma dioxin levels, modiﬁed neonatal
thyroid function.
Material and Methods
Study Population
After the Seveso accident, three zones of decreasing
contamination (A, B, and R) were delimited based on TCDD
soil concentrations. TCDD concentrations measured in soil
samples shortly after the accident were between 15.5–580.4
lg/m3 in zone A, 1.7–4.3 lg/m3 in zone B, and 0.9–1.4 lg/m3 in
zone R [19]. A cohort including all individuals living in these
three zones (804 in A, 5,941 in B, 38,624 in R) and in the
surrounding noncontaminated area (reference, 232,740 in-
dividuals) was established for follow-up studies [20]. Measure-
ments performed on plasma samples collected from
individuals within 1–2 y after the accident showed median
TCDD levels of 447 parts per trillion (ppt) in zone A (n¼296),
94 ppt in zone B (n¼ 80), and 48 ppt in zone R (n¼ 48) [21]. A
later campaign performed in 1993–1994 still found elevated
plasma levels in the exposed population, particularly among
women, who had geometric means of plasma TCDD equal to
60.5 ppt in zone A individuals (n ¼ 7), 17.6 ppt in zone B
individuals (n ¼ 51), and 6.1 ppt in individuals from the
reference area (n ¼ 52) [17].
Seveso is located in Lombardy, a region in northern Italy
with a population of 9.2 million where thyroid function is
tested in all newborns by b-TSH measurements. Blood
samples for b-TSH screening are taken 72 h after birth from
a heel prick directly onto ﬁlter paper using a standardized
collection protocol, and shipped to the Milan Central
Neonatal Screening Laboratory where b-TSH determination
is performed by ﬂuorometric immunoassay using the
AutoDELFIA automatic immunoassay system (PerkinElmer).
Since January 1, 1994, all b-TSH data have been recorded in
the Neonatal Screening Registry, which also includes infor-
mation on date and hospital of birth, weight at birth, and
place of residence. The two investigations described below
received approval from the institutional review board of the
Ospedale Maggiore Policlinico, Mangiagalli, Regina Elena
Foundation, Milan, Italy.
Residence-Based Population Study
We selected from the Seveso cohort all the 1,772 women
from the highly contaminated areas (A and B) who were: (i)
residents of zone A (n¼186) or B (n¼1,231) at the time of the
accident (July 10, 1976), or potentially exposed to TCDD,
because they moved into zone A (n ¼ 27) or B (n ¼ 328)
between July 10, 1976 and December 31, 1979; (ii) of fertile
age (i.e., date of birth after December 31, 1947); (iii) alive on
January 1, 1994. We randomly sampled 1,772 nonexposed
women from the eligible (ii and iii above) female participants
(n¼ 55,576) of the cohort established from the population of
the reference area. Nonexposed women were frequency-
matched to the exposed women by year of birth and
residence in the reference area on the date of the accident
(i above). We contacted 472 population registry ofﬁces (PROs)
of the towns of residence of the women to identify all
children born to the study participants. PRO personal
records were traced for 1,761 (99.4%) of the 1,772 women
from the contaminated areas (A and B) and 1,762 of the 1,772
women (99.4%) from the reference area. Because b-TSH
measurements for our study were obtained from the
Lombardy Neonatal Screening Registry, we excluded all
children born outside the Lombardy region (n ¼ 156; 13.3%
of the 1,170 children traced). After such exclusion, we
identiﬁed 1,014 singletons (56 from zone A, 425 from zone
B, 533 from reference) born between January 1, 1994 and
June 30, 2005 to 42 women from zone A, 327 women from
zone B, and 403 women from the reference area. For all
births, we obtained information on the type of delivery
(vaginal, cesarean) through the regional registration system of
hospital discharges. In a case-control study on chloracne
conducted between 1993–1998 [22], most of the participants
with elevated (. 0 ppt) TCDD levels were from zones A and B,
whereas only a minority of zone R individuals exhibited
elevated TCDD. In planning the residence-based population
study, we hypothesized that contrasting newborns from zones
A and B to the reference area would have provided us with
the most efﬁcient design to detect potential effects of the
exposure on neonatal TSH. Thus, the zone R population was
not included in the study.
Study Based on Plasma Dioxin Measurements
We conducted a second investigation on the children born
to the 109 women of fertile age (date of birth after 31
December 1947) who were part of the Seveso Chloracne
Study [22]. The original population sample included 211 male
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and female healthy participants representative of the Seveso
population and 101 individuals who had developed chlor-
acne, the skin disorder associated with TCDD toxicity [22]. All
participants gave written informed consent. Between 1
January 1994 and 30 June 2005, 51 children (12 from zone
A, ten from zone B, 20 from zone R, and nine from Reference)
were born to 38 of the 109 women; the remaining 71 women
did not give birth in the study period. All children from zones
A and B were also part of the residence-based population
study (which included all zone A and B women), while none
from zone R and reference had been sampled in the
residence-based population study. Dioxin measurements
were performed at the Centers for Disease Control (Atlanta,
Georgia, United States of America) using a high-resolution
gas chromatography/high-resolution mass spectrometry anal-
ysis [23] on plasma samples collected between December 1992
and September 1998. Speciﬁcally, 24 congeners were meas-
ured, including TCDD and six additional dibenzo-p-dioxins
(PCDDs), ten dibenzofurans (PCDFs), and four coplanar
PCBs. Starting from 1996, 36 non-coplanar PCBs, including
six mono-ortho congeners, were added to the panel of the
congeners we tested for. Non-coplanar PCBs were thus
measured on a subset of 37 of the 51 mother–child pairs.
Results are reported in ppt, lipid adjusted. For women with
concentrations . 10 ppt, plasma TCDD were extrapolated to
the date of delivery with a ﬁrst-order pharmacokinetic model
[24,25], using the elimination rate estimated in Seveso
(equivalent to 9.8 y half-life for women) [15].
Toxic equivalent concentrations (TEQs) were deﬁned for a
mixture of dioxin-like compounds as the product of the
concentration of each congener multiplied by its speciﬁc
toxic equivalency factor (TEF) [26]. Maternal mean TCDD
levels were 18.9 ppt (n ¼ 51, range 1.4–309.5). Mean plasma
TEQs were 44.8 ppt (n ¼ 51, range 11.6–330.4) for PCDDs,
PCDFs, and coplanar PCBs; and 1.8 ppt (n¼37, range 0.6–4.2)
for non-coplanar PCBs. Total mean TEQs, including the sum
of PCDDs, PCDFs, coplanar PCBs, and non-coplanar PCBs,
were 41.8 ppt (n¼ 37, range 12.2–334.5). Although total TEQs
also included TEQs from PCDDs, PCDFs, and coplanar PCBs,
mean total TEQs were lower than TEQs from PCDDs, PCDFs,
and coplanar PCBs. Measurement of non-coplanar PCBs,
which were used to compute total TEQs, started later during
the study (from 1996). Thus, total TEQs are available only on
a subset of participants who have lower dioxin levels likely
because of later sampling and longer time from the accident.
Statistical Analysis
b-TSH levels were log-transformed to approximate normal
distribution. Consequently, geometric b-TSH means and 95%
conﬁdence intervals (CIs) are shown. Graphical distributions
of b-TSH were plotted using the Epanechnikov kernel
function to obtain density estimates. In descriptive analyses,
we used the Fisher’s exact test to evaluate associations of the
study participant’s general characteristics with the zone of
residence, and the Student t-test for associations with b-TSH.
We calculated correlations with b-TSH and tests for trend
using linear regression analysis. Unconditional logistic
regression was used to estimate relative odds of elevated b-
TSH levels (. 5 lU/ml). In multivariate analyses, regression
models included gender, birth weight, birth order of the
newborn, and maternal age at delivery, hospital, and type of
delivery as independent variables. Correlation between
siblings was accounted for by using generalized estimating
equations in all models. However, in analysis testing differ-
ences for groups that included a very small number of
observations, generalized estimating equation may produce
unreliable results. In such instances, we used either the
Fisher’s exact test (for categorical outcomes) or Wilcoxon
(Mann-Whitney) nonparametric test (for continuous out-
comes), as indicated in the text. We performed tests for trend
across contamination zones by scoring the areas using the
logarithm of the geometric means of plasma TCDD (60.5 ppt
in zone A, 17.6 ppt in zone B, and 6.1 ppt in the reference
area) measured in female participants in a previous inves-
tigations conducted between 1993–1995 [17]. In the resi-
dence-based population study, results did not show major
differences after excluding 66 children (6.5% of the total
sample size) born to mothers who had moved into the study
areas after the date of the accident. Results including all
newborns are reported throughout the paper. In the study
based on plasma dioxin, information on additional possible
confounders, including maternal body mass index (BMI),
smoking habits, alcohol consumption, and neonatal age in
hours at b-TSH measurement, was available. In multivariate
models, inclusion or exclusion of these variables did not
modify statistical signiﬁcance. To conﬁrm the results of linear
models, we used Spearman’s rank-correlation statistics. In
both studies, statistical signiﬁcance was not modiﬁed by
adding to the models indicator variables for year of birth to
adjust for trends through the study period. All tests were two-
sided. All analyses were performed in Stata 9.0 (Stata
Corporation).
Results
Residence-Based Population Study
The characteristics of the newborns included in the
residence-based population study were similar across the
three contamination zones (Table 1). Neonatal b-TSH values
ranged between 0.2 and 14.0 lU/ml. Mean neonatal b-TSH
decreased with increasing birth weight (p ¼ 0.03), consistent
with previous observations on other populations [27], and
showed moderate, nonsigniﬁcant variations in association
with birth order and type of delivery (Table 1). Mean neonatal
b-TSH levels were signiﬁcantly higher in the populations who
lived in the TCDD-contaminated zones at the time of the
accident (Table 2). Mean b-TSH was 0.98 lU/ml (95% CI 0.90–
1.08) in the reference population, 1.35 lU/ml (95% CI 1.22–
1.49) in zone B, and 1.66 lU/ml (95% CI 1.19–2.31) in zone A,
the most contaminated area (p , 0.001 for trend across
zones). Distributions of b-TSH by contamination zones are
shown in Figure 1. The proportion of newborns with b-TSH
. 5 lU/ml (Table 3) was equal to 2.8% in the reference area,
4.9% in zone B, and 16.1% in zone A (p , 0.001). Compared
to the reference area, the relative odds of elevated b-TSH
increased through contamination zones, with odds ratio (OR)
¼ 1.79 (95% CI 0.92–3.50) for zone B and OR¼ 6.60 (95% CI
2.45–17.8) for zone A (p ¼ 0.002 for trend across zones).
Eight of the newborns in our study (three from reference
[0.6%], four from zone B [0.9%], and one from zone A [1.8%])
had b-TSH levels . 10 lU/ml, which is set as the recall
threshold for further laboratory and clinical investigations in
Lombardy Region. Two of them (one from zone B [0.2%] and
one from zone A [1.8%]) had b-TSH . 10 lU/ml twice in
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recall tests and were eventually diagnosed with congenital
primary hypothyroidism (p ¼ 0.049, Fisher’s exact test). The
remaining ﬁve children all had b-TSH , 5 lU/ml at the ﬁrst
recall and did not undergo further testing.
In this study, 228 women had more than one child during
the study period. We calculated the difference in b-TSH
between the ﬁrst and the second child (228 pairs), and
between the third and the second child (14 pairs). Neonatal b-
TSH decreased with time between one birth and the next
(Table 4) in the contaminated zones (A and B), while no
decrease was found in the reference population (p¼ 0.03 for
the interaction with zones).
All results in the residence-based population study were
similar after adjustment for gender, birth weight, birth order,
maternal age at delivery, hospital, and type of delivery (Tables
2–4).
Study Based on Plasma Dioxin Measurements
Maternal TCDD levels estimated at the date of delivery
were positively associated with neonatal b-TSH (n ¼ 51,
standardized regression coefﬁcient [b] ¼ 0.47, p , 0.001,
Figure 2A). When also other dioxin congeners were consid-
ered, a similar correlation was found with plasma TEQs for
PCDDs, PCDFs, and coplanar PCBs (n¼51, b¼0.45, p¼0.005,
Figure 2B), but not with non-coplanar PCBs (n¼37, b¼0.16, p
¼ 0.45, Figure 2C). Multivariate regression models adjusting
for gender, birth weight, birth order, maternal age at delivery,
hospital, and type of delivery conﬁrmed the association of
neonatal b-TSH with plasma TCDD (b ¼ 0.75, p , 0.001),
PCDDs, PCDFs, and coplanar PCBs (b¼ 0.68, p , 0.001), and
the lack of signiﬁcant correlation with non-coplanar PCBs (b
¼ 0.24, p ¼ 0.46). When the sum of all total TEQs from the
measured compounds was considered, the correlation with
neonatal b-TSH levels was not signiﬁcant in the crude
analysis (n ¼ 37, b ¼ 0.31, p ¼ 0.14, Figure 2D). However, in
the multivariate analysis the correlation was signiﬁcant (b ¼
0.65, p , 0.001).
We performed regression diagnostics and sensitivity
analyses to evaluate the role of inﬂuential data points in
our analyses [28]. We identiﬁed inﬂuential points using either
of the following two criteria: (i) largest Cook’s distance
(highest 5%); (ii) strongest impact on the TSH-exposure slope
(highest 5% difference). Including or removing single
inﬂuential points did not modify the strength of the positive
association between maternal plasma levels of dioxins and
neonatal TSH levels, which always remained statistically
signiﬁcant at the 0.05 level. All positive associations were
dependent on the presence in the analyses of participants
with very high plasma TCDD level (. 50 ppt, n¼ 5). When the
analysis was restricted to individuals with TCDD  50 ppt,
none of the correlations described above was statistically
signiﬁcant. However, when the nonparametric Spearman’s
rank correlation coefﬁcients (rs) were used, the associations of
b-TSH with plasma TCDD (rs¼ 0.28, p ¼ 0.04), and TEQs for
PCDDs, PCDFs, and coplanar PCBs (rs ¼ 0.33, p ¼ 0.02) were
signiﬁcant.
When newborns were divided by contamination zones,
correlations with neonatal b-TSH were highest in zone A for
both plasma TCDD (rs ¼ 0.70, p ¼ 0.01), and PCDD, PCDFs,
Table 1. Characteristics, Dioxin Contamination Zones, and Neonatal b-TSH Levels of the Mother–Child Pairs Included in the 1994–2005
Seveso Population-Based Study
Variable Category Zone of Residence of the Mothers at the Accident Neonatal b-TSH (lU/ml)
Reference
(n ¼ 533)
Zone B
(n ¼ 425)
Zone A
(n ¼ 56)
p-Value* na Meanb 95% CIb p-Valueb
na Percent na Percent na Percent
Gender of
the newborn
Male 264 49.5 216 50.8 32 57.1 — 513 1.21 1.10–1.33 —
Female 269 50.5 209 49.2 24 42.9 0.55 501 1.10 1.01–1.21 0.16
Birth weight (g) ,2,500 31 5.9 22 5.2 1 1.8 — 54 1.58 1.20–2.08 —
2,500–2,999 107 20.3 88 21.0 10 17.9 — 205 1.24 1.07–1.44 —
3,000–3,499 236 44.7 179 42.7 32 57.1 — 447 1.12 1.01–1.24 —
2,500–4,000 121 22.9 108 25.8 12 21.4 — 241 1.12 0.98–1.28 —
.4,000 33 6.2 22 5.2 1 1.8 0.82 56 1.04 0.77–1.39 0.03
Maternal age
at delivery (y)
,29 130 24.3 104 24.5 17 30.3 — 251 1.17 1.02–1.35 —
29–31 140 26.3 114 26.8 15 26.8 — 269 1.25 1.11–1.42 —
32–34 140 26.3 111 26.1 14 25.0 — 265 1.02 0.89–1.16 —
35 123 22.6 96 22.6 10 17.9 0.51 229 1.20 1.04–1.37 0.57
Birth orderc First 403 75.6 327 76.9 42 75.0 — 772 1.14 1.06–1.23 —
Second 122 22.9 94 22.1 12 21.4 — 228 1.20 1.05–1.37 —
Third 8 1.5 4 0.9 2 3.6 0.74 14 1.29 0.59–2.80 0.49
Type of delivery Vaginal 422 79.2 348 81.9 46 82.1 — 816 1.13 1.04–1.22 —
Cesarean 111 20.8 77 18.1 10 17.8 0.57 198 1.27 1.10–1.46 0.18
aCounts may not add up to the total number of newborns due to missing information for some of the mother–child pairs.
bGeometric b-TSH means and their 95% CIs are reported. p-Values are computed from t-test (two-class variables) or test for trend (variables with three or more categories) performed on
log-transformed b-TSH values.
cInformation on births only between January 1, 1994 and June 30, 2005 was available for this study.
*p-Values from Fisher’s exact test (two-class variables) or test for trend based on Spearman’s statistics (variables with three or more categories).
doi:10.1371/journal.pmed.0050161.t001
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and coplanar PCBs (rs ¼ 0.82, p ¼ 0.001), whereas in the
reference area no association was found with either plasma
TCDD (rs ¼0.25; p ¼ 0.51), or PCDD, PCDFs, and coplanar
PCBs (rs¼ 0.11, p ¼ 0.78).
The analyses described above were based on plasma TCDD
levels that, for women with plasma TCDD . 10 ppt, were
extrapolated to the date of delivery using a ﬁrst-order
pharmacokinetic model. Using the measured TCDD concen-
trations in place of the extrapolated levels affected the results
only marginally. In particular, neonatal b-TSH levels ex-
hibited signiﬁcant associations in multivariable models with
plasma TCDD (b¼ 0.68, p¼ 0.002); plasma TEQs for PCDDs,
PCDFs, and coplanar PCBs (b¼0.60, p¼0.004); and sum of all
total TEQs (b ¼ 0.65, p ¼ 0.001).
As shown in Table 5, plasma dioxin levels were signiﬁcantly
higher in newborns with b-TSH . 5 lU/ml. Plasma TCDD was
5.2 ppt (95% CI 4.1–6.7) in newborns with b-TSH  5 lU/ml
and 39.0 ppt (95% CI 8.9–173) in those with b-TSH . 5 lU/ml
(p ¼ 0.005). Plasma TEQs for PCDDs, PCDFs, and coplanar
PCBs were 30.6 ppt (95% CI 26.9–34.8) in newborns with b-
TSH  5 lU/ml and 88.9 ppt (95% CI 43.1–183.5) in those
with b-TSH . 5 lU/ml (p¼ 0.002). Also, in the group with b-
TSH ,5 lU/ml non-coplanar PCBs levels (1.5 ppt, 95% CI
1.2–1.8) and the sum of all TEQs (29.2 ppt, 95% CI 25.3–33.5)
were signiﬁcantly different from the levels found in the in the
group with b-TSH  5 lU/ml (2.9 ppt, 95% CI 1.8–4.6, p ¼
0.003 for non-coplanar PCBs; 84.5 ppt, 95% CI 16.7–427.8, p¼
0.01 for the sum of all TEQs).
Discussion
Neonatal b-TSH, which is used in most countries to screen
for congenital hypothyroidism, is considered a sensitive
marker of subclinical primary hypothyroidism and a suitable
index of the presence of factors causing thyroid enlargement
and potential alterations in function [1,29,30]. Our results
from the Seveso population showed that newborns of
mothers with high body burdens of TCDD, resulting from
accidental dioxin exposure occurring approximately 20–30 y
earlier, had higher neonatal b-TSH concentrations compared
to newborns of nonexposed women.
In our residence-based population study, we observed a
shift in the distribution of b-TSH toward higher levels in the
exposed groups, thus suggesting that dioxin exposure may
produce effects that are detectable at the population level.
Mean b-TSH levels increased through the contamination
zones, with proportions of b-TSH . 5 lU/ml in the highly
contaminated areas (zones A and B) equivalent to those
associated with mild iodine deﬁciency (3%–19.9% according
to the WHO) [1]. Epidemiological studies conducted in areas
with mild to moderate iodine deﬁciency have demonstrated,
even in the absence of clinical hypothyroidism, abnormalities
in psychoneuromotor and intellectual development, includ-
ing impairment of visual-motor performances, motor skills,
perceptual and neuromotor abilities, as well as reduced
development and intellectual quotients (IQs) [29,31]. Post-
natal cognitive and motor alterations have also been
described in children with perinatal exposure to dioxin-
related compounds [10,32–36]. At the individual level, only
eight of the newborns in our study had b-TSH levels . 10 lU/
Figure 1. Distribution of Neonatal b-TSH by Dioxin Contamination Zone
Neonatal b-TSH distribution for children born between 1994 and 2005 to
women from zone A (n¼54), the zone most contaminated by TCDD after
the Seveso accident; zone B (n ¼ 425); and the surrounding non-
contaminated reference area (n¼ 533). The graph shows kernel density
estimates by zones.
*According to the WHO [1], the percentage at the population level of
newborns with a b-TSH value greater than 5 lU/ml should be less than
3% in iodine-replete areas.
doi:10.1371/journal.pmed.0050161.g001
Table 2. Neonatal b-TSH Levels in Children Born between 1994 and 2005 to Women from Zone A (the Zone Most Contaminated after
the Seveso Accident), Zone B, and the Surrounding Noncontaminated Area (Reference)
Zone n Crude Multivariate Analysisa
Mean b-TSHb 95% CI p-Trendc Mean b-TSHb 95% CI p-Trendc
Reference 533 0.98 0.90–1.08 — 0.99 0.90–1.08 —
B 425 1.35* 1.22–1.49 — 1.35* 1.23–1.50 —
A 56 1.66* 1.19–2.31 ,0.001 1.63* 1.13–2.33 ,0.001
aEstimates from generalized estimating equations analysis adjusted for gender, birth weight, birth order, maternal age at delivery, hospital, and type of delivery.
bStatistical analyses were performed on log-transformed b-TSH values to approximate normal distribution. Geometric b-TSH means and 95% CIs are reported.
cRegression-based Wald-test for trend in b-TSH levels across the three zone categories performed by scoring the three zones based on plasma TCDD levels measured in female
participants from the Seveso area (see Statistical Methods [17]).
*p , 0.01 versus reference.
doi:10.1371/journal.pmed.0050161.t002
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ml, which is commonly set as the recall threshold for further
laboratory and clinical investigations for congenital hypo-
thyroidism. After further testing, two children from the
contaminated areas and none from the reference were
diagnosed with primary hypothyroidism. Our residence-
based population study did not include women from the
zone R area, which was an area with low-level and patchy
contamination, representing a circular strip between the
highly contaminated zones (A and B) and the surrounding
reference area [20]. Additional research is warranted to
determine whether neonatal thyroid function has been
altered by dioxin exposure in the zone R population.
Plasma dioxin has been shown in Seveso and elsewhere to
decrease exponentially with time in individuals with high
body burdens, while it is nearly constant in individuals with
background exposure [24,25]. In our residence-based pop-
ulation study, the analysis of changes in neonatal b-TSH
between siblings from the contaminated zones showed that b-
TSH was higher in the ﬁrst child and tended to decrease with
time in subsequent children. No time-related decrease in b-
TSH was seen in the reference zone. This ﬁnding provides
indirect evidence for a decrease of dioxin effects on neonatal
b-TSH in conjunction with the time-related elimination of
dioxin described in Seveso [15].
Our analysis based on dioxin plasma measurements
conﬁrmed the results of the residence-based population
study and permitted directly conﬁrming the presence of a
positive correlation of b-TSH levels with current plasma
TCDD estimated at birth, as well as with TEQs of dioxin-like
compounds. Persistence of elevated TCDD levels more than
20 y after the accident and the relative strength of the
associations suggest that TCDD was the main factor driving
the relation between dioxin plasma concentrations and b-
TSH. Exposure in the Seveso accident was predominantly to
TCDD [14], and the associations we observed with neonatal b-
TSH may reﬂect differences in exposure dose, as well as
differential susceptibility in the infants to dioxin effects.
Our results, showing higher b-TSH levels in TCDD-exposed
individuals, are consistent with animal investigations indicat-
ing that maternal TCDD exposure induces elevated b-TSH
and neonatal primary hypothyroidism [2,7,8,10]. Previous
investigations in humans, which have measured thyroid
function and TCDD exposure in mother–child pairs from
the general population, produced inconsistent results [2].
Initial reports from the Netherlands suggested that infants
born to mothers with PCDD, PCDF, and PCB concentrations
on the higher side of the population range had higher plasma
TSH levels [37,38]. Koopman-Esseboom et al. [37] evaluated
thyroid function on 78 breast-fed children at 2 wk and 3 mo
of age. Levels of 22 individual PCDD, PCDF, and PCB
Table 4. Variations in Neonatal b-TSH between Siblings born between 1994 and 2005 to Women from Zone A, the Zone Most
Contaminated after the Seveso Accident, Zone B, and the Surrounding Noncontaminated Area (Reference)
Zone Number of Sib Pairs Crude Multivariate Analysisa
bb 95% CI Interaction Testc bb 95% CI Interaction Testc
Reference 130 0.09 0.06, 0.25 — 0.09 0.07, 0.26 —
B 98 0.12 0.27, 0.03 — 0.12 0.27, 0.04 —
A 14 0.33 0.63, 0.03 0.03 0.33 0.64, 0.02 0.03
aVariation of b-TSH and 95% CI for each year elapsed between the birth of two siblings estimated through generalized estimating equations analysis adjusted for gender, birth weight,
birth order, maternal age at delivery, hospital, and type of delivery.
bIncrease in b-TSH levels between siblings for each year from the birth of the previous sibling.
cp-Value obtained from generalized estimating equations analysis including a term for interaction between time and zones (the three zones were scored based on plasma TCDD levels
measured in female participants from the Seveso area) (see Statistical Methods [17]).
doi:10.1371/journal.pmed.0050161.t004
Table 3. Frequency and Relative Odds of Elevated Neonatal b-TSH Levels (. 5 lU/ml) in Children Born between 1994 and 2005 to
Women from Zone A (the Zone Most Contaminated after the Seveso Accident), Zone B, and the Surrounding Noncontaminated Area
(Reference)
Zone b-TSH  5 lU/mla b-TSH . 5 lU/mla Crude Multivariate Analysisb
n Percent n Percent OR 95% CI p-Trend OR 95% CI p-Trend
Reference 518 97.2% 15 2.8% Reference — — Reference — —
B 404 95.1% 21 4.9% 1.79 0.92–3.50 — 1.90 0.94–3.86 —
A 47 83.9% 9 16.1% 6.60* 2.45–17.8 0.001 6.63* 2.36–18.6 0.001
According to the WHO [1], the percentage at the population level of newborns with a b-TSH value greater than 5 lU/ml should be less than 3% in iodine-replete areas.
aRegression-based Wald-test for trend in b-TSH levels across the three zone categories performed by scoring the three zones based on plasma TCDD levels measured in female
participants from the Seveso area (see Statistical Methods [17]).
bORs, 95% CIs, and p-values estimated through generalized estimating equations analysis adjusted for gender, birth weight, birth order, maternal age at delivery, hospital, and type of
delivery.
*p , 0.001 versus reference.
doi:10.1371/journal.pmed.0050161.t003
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congeners, measured in human milk samples, were within
background levels and correlated with higher infant plasma
TSH levels measured in the second week and third month
after birth. In a subsequent study, Pluim et al. [38] performed
thyroid function tests in 38 breast-fed infants at birth and at 1
and 11 wk of age and found that infants breast-fed with milk
containing TEQ levels above the median of the study group
had higher mean plasma TSH at 11 wk of age, relative to
infants below the TEQ median, while TSH levels were not
different between the two groups at birth and 1 wk after
birth.
After these two initial reports, a series of studies have been
conducted that have not conﬁrmed the association between
dioxin exposure and thyroid function alterations [39–42].
The largest of these studies, which was conducted in Japan,
showed no association of serum TSH, total T4, total T3, and
free T4, measured on 337 breast-fed children at 1 y of age,
with breast milk TEQ background levels from 41 PCDD,
PCDF, and PCB congeners measured in maternal breast milk
30 d after birth [40]. More recently, a study conducted on a
sample of 118 children from the general population of
central Taiwan found in female newborns, but not in males, a
negative correlation between cord b-TSH levels and TEQ
levels from 17 PCDDs and PCDFs, and 12 PCBs measured in
placental tissue [43]. A recent study that used the CALUX
assay as a functional measure of dioxin activity on cord blood
Table 5. Plasma Levels of Dioxin Compounds by b-TSH Levels ( 0.5 lU/ml or . 5 lU/ml)
Dioxin Compounds b-TSH  5 lU/mla b-TSH . 5 lU/mla p-Valueb
n Geometric Mean (TEQs, ppt) 95% CI n Geometric Mean (TEQs, ppt) 95% CI
TCDD 44 5.2 4.1–6.7 7 39.0 8.9–173 0.002
PCDD, PCDFs, coplanar PCBs 44 30.6 26.9–34.8 7 88.9 43.1–183.5 0.001
Non-coplanar PCBs 33 1.5 1.2–1.8 4 2.9 1.8–4.6 0.008
Sum of all TEQs 33 29.2 25.7–33.5 4 84.5 16.7–427.8 0.01
aAccording to the WHO [1], the percentage at the population level of newborns with a b-TSH value greater than 5 lU/ml should be less than 3% in iodine-replete areas.
bWilcoxon (Mann-Whitney) nonparametric test for the difference in congener levels between b-TSH groups.
doi:10.1371/journal.pmed.0050161.t005
Figure 2. Plasma Dioxin Levels and Neonatal b-TSH
Neonatal b-TSH and maternal plasma levels of dioxin-related compounds estimated at the date of delivery for (A) TCDD; (B) PCDDs, PCDFs, coplanar
PCB TEQs; (C) non-coplanar PCB TEQs; and (D) total TEQs (i.e., the sum of TEQs from all measured congeners, including PCDDs, PCDFs, coplanar PCBs,
and non-coplanar PCBs).
Number of mother–child pairs (n), standardized regression coefficients (b), and p-values (p) from models using generalized estimating equations are
reported.
doi:10.1371/journal.pmed.0050161.g002
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samples from 198 newborns observed a negative association
with cord blood free T3 and T4, but not with TSH [44]. Several
studies have investigated the association of dioxin-like and
nondioxin-like PCBs on neonatal thyroid function [45–49],
reporting associations of either the sum of PCBs or individual
congeners with decreased free T4 [45,46], and increased TSH
[47,48], though between-study consistency was limited. Dis-
crepancies among studies may reﬂect random variability in
investigations with relatively small sample size, likely to have
insufﬁcient statistical power to detect potentially subtle
effects from low dioxin and PCB levels [2]. Our study has
the advantage of being based on a unique population of
women exposed to high levels of TCDD. Our residence-based
population study included over 1,000 newborns whose
thyroid function was evaluated after birth using standardized
procedures for blood sample collection, handling, and ship-
ment. b-TSH measurements were performed at a single
laboratory using the same method throughout the study
period. Our study based on plasma dioxin measurements,
which was conducted on a smaller sample of individuals only
partially included in the residence-based population study,
allowed for the evaluation of the dose-effect relationship with
different metrics of dioxin concentrations. Because b-TSH
levels were measured 72 h after birth in our study, mother–
child dioxin transfer through colostrum [50] might have
contributed to the correlation in our study between dioxin
and b-TSH levels. Because we did not have information on
breast-feeding before b-TSH measurement, the relative
contribution of dioxins from colostrum could not be assessed
in our study.
In all our analyses, we adjusted for potential determinants
of b-TSH or TCDD levels, including gender, birth weight,
birth order of the newborn, maternal age at delivery, hospital,
and type of delivery. Information on other determinants of
neonatal b-TSH levels, including maternal iodine intake, was
not available. However, there is no indication that exposed
and unexposed women had differences in iodine intake in the
study period. The exposed and referent populations all lived
in a relatively small geographical area at the time of the
accident [14]. Changes of residence immediately after the
accident and later migrations determined geographical
distributions across the Lombardy region that are very
similar for the exposed and reference populations
[14,20,51]. All available indicators have shown close compa-
rability in terms of social, educational, cultural, and occupa-
tional characteristics, as well as of access to health-care
services, including primary care physicians, obstetrics and
gynecology specialists, and hospital care [14,20,52]. In
addition, by adjusting for hospital of birth in multivariable
models, we also controlled in our analyses for geographical
location, thus reducing the likelihood that systematic
environmental differences in iodine concentrations between
exposed and reference populations might have biased the
results.
Our ﬁndings from the Seveso population indicate that
maternal exposure to persistent environmental contaminants
such as TCDD produces effects on neonatal thyroid function
that may occur far apart in time from the initial exposure. To
clarify the clinical signiﬁcance of our ﬁndings, further
investigation on developmental outcomes after maternal
dioxin exposure is warranted.
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Editors’ Summary
Background. The thyroid, a butterfly-shaped gland in the neck, controls
the speed at which the human body converts food into the energy and
chemicals needed for life. In healthy people, the thyroid makes and
releases two hormones (chemical messengers that travel around the
body and regulate the activity of specific cells) called thyroxine (T4) and
triiodothyronine (T3). The release of T4 and T3 is controlled by thyroid
secreting hormone (TSH), which is made by the pituitary gland in
response to electrical messages from the brain. If the thyroid stops
making enough T4 and T3, a condition called hypothyroidism (an
underactive thyroid) develops. Adults with hypothyroidism put on
weight, feel the cold, and are often tired; children with hypothyroidism
may also have poor growth and mental development. Because even a
small reduction in thyroid hormone levels increases TSH production by
the pituitary, hypothyroidism is often diagnosed by measuring the
amount of TSH in the blood; it is treated with daily doses of the synthetic
thyroid hormone levothyroxine.
Why Was This Study Done? Although hypothyroidism is most common
in ageing women, newborn babies sometimes have hypothyroidism. If
untreated, ‘‘neonatal’’ hyperthyroidism can cause severe mental and
physical retardation so, in many countries, blood TSH levels are
measured soon after birth. That way, levothyroxine treatment can be
started before thyroid hormone deficiency permanently damages the
baby’s developing body and brain. But what causes neonatal hypo-
thyroidism? Animal experiments (and some but not all studies in people)
suggest that maternal exposure to toxic chemicals called dioxins may be
one cause. Dioxins are byproducts of waste incineration that persist in
the environment and that accumulate in people. In this study, the
researchers investigate whether exposure to dioxin (this name refers to
the most toxic of the dioxins—2,3,7,8-Tetrachlorodibenzo-p-dioxin)
affects neonatal thyroid function by studying children born near Seveso,
Italy between 1994 and 2005. An accident at a chemical factory in 1976
heavily contaminated the region around this town with dioxin and, even
now, the local people have high amounts of dioxin in their bodies.
What Did the Researchers Do and Find? The researchers identified
1,772 women of child-bearing age who were living very near the Seveso
factory (the most highly contaminated area, zone A) or slightly further
away where the contamination was less but still high (zone B) at the time
of the accident or soon after. As controls, they selected 1,772 women
living in the surrounding, noncontaminated (reference) area. Altogether,
these women had 1,014 babies between 1994 and 2005. The babies born
to the mothers living in the reference area had lower neonatal blood TSH
levels on average than the babies born to mothers living in zone A; zone
B babies had intermediate TSH levels. Zone A babies were 6.6. times
more likely to have a TSH level of more than 5 lU/ml than the reference
area babies (the threshold TSH level for further investigations is 10 lU/
ml; the average TSH level among the reference area babies was 0.98 lU/
ml). The researchers also examined the relationship between neonatal
TSH measurements and maternal dioxin measurements at delivery
(extrapolated from measurements made between 1992 and 1998) in 51
mother–baby pairs. Neonatal TSH levels were highest in the babies
whose mothers had the highest blood dioxin levels.
What Do These Findings Mean? These findings suggest that maternal
dioxin exposure has a long-lasting, deleterious effect on neonatal thyroid
function. Because the long-term progress of the children in this study
was not examined, it is not known whether the increases in neonatal TSH
measurements associated with dioxin exposure caused any develop-
mental problems. However, in regions where there is a mild iodine
deficiency (the only environmental exposure consistently associated with
reduced human neonatal thyroid function), TSH levels are increased to a
similar extent and there is evidence of reduced intellectual and physical
development. Future investigations on the progress of this group of
children should show whether the long-term legacy of the Seveso
accident (and of the high environmental levels of dioxin elsewhere)
includes any effects on children’s growth and development.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0050161.
 The MedlinePlus encyclopedia provides information about
hypothyroidism and neonatal hypothyroidism; MedlinePlus provides
links to additional information on thyroid diseases (in English and
Spanish)
 The UK National Health Service Direct health encyclopedia provides
information on hypothyroidism
 The Nemours Foundation’s KidsHealth site has information written for
children about thyroid disorders
 Toxtown, an interactive site from the US National Library of Science,
provides information on environmental health concerns including
exposure to dioxins (in English and Spanish)
 More information about dioxins is provided by the US Environmental
Protection Agency and by the US Food and Drug Administration
 Wikipedia has a page on the Seveso disaster (note: Wikipedia is a free
online encyclopedia that anyone can edit; available in several
languages)
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